Our Science

The science leads.

We don’t sell hype. We report what the research shows.

The formulation

Works for Glucose Wellness is a precision-probiotic capsule. Three Generally Recognized as Safe (GRAS)-designated strains:

  • Lactobacillus rhamnosus ATCC 7469
  • Lactobacillus reuteri ATCC 23272
  • Lactobacillus salivarius ATCC 11741

Vegan HPMC capsule. Non-GMO, Gluten-Free, Dairy-Free, Soy-Free, Vegan. Patent pending.

How the strains were chosen

The strains were selected by AI-driven in silico prediction from 1,000+ candidates, narrowed to three by in vitro glucose-consumption screening, then tested in vivo in an eight-week preclinical study. This is precision selection, not guesswork. The formulation is licensed from Arizona State University and is patent pending.

The evidence

The formulation is backed by published, peer-reviewed preclinical research.

Precision Probiotics Regulate Blood Glucose, Cholesterol, Body Fat Percentage, and Weight Under Eight-Week High-Fat Diet

Chi J, Patterson JS, Li L, Lalime N, Hawley D, Kim KJ, Liu L, Cui JY, Sears DD, Jasbi P, Gu H.

Metabolites 2025;15(10):642 · doi:10.3390/metabo15100642 · PMID 41149620

Two of the authors lead Works: Paniz Jasbi, our Chief Executive Officer, and Haiwei Gu, our Chief Science Officer.

A human study is IRB approved and will commence Fall 2026.

This research is preclinical. We describe it as preclinical because that is what it is. We will report human results when we have them.

How Works is made

Works is produced in the United States at a 21 CFR 111, cGMP-compliant facility, weighed, blended, filled, and inspected by hand, batch by batch.

Precision weighing during manufacturing Filling and quality check during manufacturing Inspecting a finished batch at the facility A lab technician running a quality check during manufacturing

The team

Paniz Jasbi, PhD

Paniz Jasbi, PhD, Chief Executive Officer. Metabolomics scientist and author of more than 40 peer-reviewed publications in systems biology. Inventor and entrepreneur.

Alex Mohr, PhD

Alex Mohr, PhD, Chief Product Officer. Gut microbiome scientist and author of dozens of peer-reviewed papers, with a career spanning academia, government, and private industry. Former NIH postdoctoral researcher.

Haiwei Gu, PhD

Haiwei Gu, PhD, Chief Science Officer. Professor at Arizona State University and author of more than 150 peer-reviewed publications. Pioneer of metabolic profiling and head of strain development at Works.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.